Citigroup
VXRT

Citigroup’s Vaxart VXRT Stock Holding History

Citigroup’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-106,500
Closed -$608K – 7480
2020
Q4 		$608K Buy
+106,500
New +$677K ﹤0.01% 4028

Other funds holding VXRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citigroup's VXRT Position: Q1 2025 in Review

Citigroup sold out of Vaxart (VXRT) in Q1 2025, closing a stake of 1,464 shares — an estimated $969 sold.

Citigroup first reported a position in VXRT in Q2 2013 and held it in 22 quarters. The position peaked at $4.14M in Q4 2021. 92 funds tracked by Wall St. Rank hold VXRT as of Q1 2025.

  • Citigroup reported no remaining Vaxart position as of Q1 2025 after selling out during the quarter.
  • Citigroup sold 1,464 Vaxart shares in Q1 2025, an estimated $969.
  • Citigroup first reported a position in Vaxart in Q2 2013 and held it in 22 quarters.
  • Citigroup's Vaxart position peaked at $4.14M in Q4 2021.
  • 92 funds tracked by Wall St. Rank held Vaxart as of Q1 2025.

Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.